Document is current
Any future updates will be listed below
-
Authors
Ahel, Juraj https://orcid.org/0000-0003-0293-1063
Balci, Arda
Faas, Victoria
Grabarczyk, Daniel B. https://orcid.org/0000-0003-0216-7085
Harmo, Roosa
Squair, Daniel R.
Zhang, Jiazhen
Roitinger, Elisabeth https://orcid.org/0000-0002-3405-7801
Lamoliatte, Frederic
Mathur, Sunil
Deszcz, Luiza
Bell, Lillie E. https://orcid.org/0009-0001-9398-4031
Lehner, Anita
Williams, Thomas L.
Sowar, Hanna
Meinhart, Anton
Wood, Nicola T. https://orcid.org/0000-0002-3347-6625
Clausen, Tim https://orcid.org/0000-0003-1582-6924
Virdee, Satpal https://orcid.org/0000-0002-7052-9802
Fletcher, Adam J. https://orcid.org/0000-0003-1742-6588
-
Funding
Funding for this research was provided by:
RCUK | MRC | Medical Research Foundation (MR/T043482/1)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 24 April 2025
First Online: 13 May 2025
Competing interests
: S.V. is an author of a patent relating to the ABP technology and is also Founder and shareholder of Outrun Therapeutics. The remaining authors declare no competing interests.
